AMPLY DISCOVERY EXPLAINS HOW ITS AI TECHNOLOGY CAN IDENTIFY NOVEL BIOLGICAL DRUG CANDITATES
CEO, Ben Thomas, and CCO, Dermot Tierney, joined Moira Gunn from BioTech Nation to discuss exactly why the company was formed and how, with the assistance of AI and machine learning, it’s technology can identify novel biological drug and nutraceutical candidates Click here to listen. Podcast taken from: https://www.biotechnation.com/episodes/why-do-ai-one-way-when-you-can-do-it-25-dr-ben-thomas-and-dermot-tierny-ceo-cco-amply-discovery









